BTAIVSLTRN• 12 Months (Normalized)
BTAI vs LTRN (BioXcel Therapeutics Inc. vs Lantern Pharma Inc.)
Showing Closing Date Range from Sep, 18, 2025 to Sep, 18, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.08
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
LTRN Performance $1.58
-61.3%
Lantern Pharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin BTAI LEADS
+61.3%
BTAI outperforming by 61.30%
BTAILTRN
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI LTRN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | BTAI Price | BTAI Gain (%) | LTRN Price | LTRN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 18, 2026 | $- | $1.58 | -61.30% | - | |
| Sep 17, 2026 | $0.08 | -97.50% | $1.71 | -57.99% | -39.51% |
| Sep 16, 2026 | $0.07 | -97.78% | $1.93 | -52.58% | -45.20% |
| Sep 15, 2026 | $0.04 | -98.51% | $1.70 | -58.23% | -40.28% |
| Sep 14, 2026 | $0.05 | -98.50% | $1.71 | -57.99% | -40.51% |
| Sep 11, 2026 | $0.05 | -98.31% | $1.71 | -57.99% | -40.32% |
| Sep 10, 2026 | $0.05 | -98.34% | $1.76 | -56.76% | -41.58% |
| Sep 09, 2026 | $0.05 | -98.44% | $1.77 | -56.51% | -41.93% |
| Sep 08, 2026 | $0.04 | -98.57% | $1.84 | -54.79% | -43.78% |
| Sep 04, 2026 | $0.07 | -97.54% | $1.91 | -53.19% | -44.35% |
| Sep 03, 2026 | $0.12 | -96.08% | $1.87 | -54.05% | -42.03% |
| Sep 02, 2026 | $0.11 | -96.45% | $1.93 | -52.58% | -43.87% |
| Sep 01, 2026 | $0.14 | -95.45% | $2.02 | -50.37% | -45.08% |
| Aug 31, 2026 | $0.16 | -94.58% | $2.03 | -50.12% | -44.46% |
| Aug 28, 2026 | $0.18 | -93.99% | $2.07 | -49.14% | -44.85% |
Page 1 of 17